Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher N Luscombe

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
SLAS Discovery : Advancing Life Sciences R & D|August 21, 2019
Using Physicochemical Measurements to Influence Better Compound DesignShenaz B Bunally, Christopher N Luscombe, Robert J Young
Journal of Chemical Information and Modeling|March 12, 2009
Analysis of the calculated physicochemical properties of respiratory drugs: can we design for inhaled drugs yet?Timothy J Ritchie, Christopher N Luscombe, Simon J F Macdonald
Molecular Pharmaceutics|March 26, 2016
Integrating in Silico and in Vitro Approaches To Predict Drug Accessibility to the Central Nervous SystemYan-Yan Zhang, Houfu Liu, Scott G Summerfield, et al.
Drug Discovery Today|June 28, 2011
Getting physical in drug discovery II: the impact of chromatographic hydrophobicity measurements and aromaticityRobert J Young, Darren V S Green, Christopher N Luscombe, et al.
Journal of Computer-Aided Molecular Design|April 26, 2013
QSAR workbench: automating QSAR modeling to drive compound designRichard Cox, Darren V S Green, Christopher N Luscombe, et al.
European Journal of Medicinal Chemistry|July 20, 2002
On the mechanism of human intestinal absorptionMichael H Abraham, Yuan H Zhao, Joelle Le, et al.
Journal of Medicinal Chemistry|October 12, 2016
Correction to Evolution of a Novel, Orally Bioavailable Series of PI3Kδ Inhibitors from an Inhaled Lead for the Treatment of Respiratory DiseaseAugustin Amour, Nick Barton, Anthony W J Cooper, et al.
Journal of Medicinal Chemistry|July 19, 2016
Evolution of a Novel, Orally Bioavailable Series of PI3Kδ Inhibitors from an Inhaled Lead for the Treatment of Respiratory DiseaseAugustin Amour, Nick Barton, Anthony W J Cooper, et al.
Journal of Medicinal Chemistry|August 23, 2016
Correction to Evolution of a Novel, Orally Bioavailable Series of PI3Kδ Inhibitors from an Inhaled Lead for the Treatment of Respiratory DiseaseAugustin Amour, Nick Barton, Anthony W J Cooper, et al.
Journal of Chemical Information and Modeling|September 30, 2010
Lead optimization using matched molecular pairs: inclusion of contextual information for enhanced prediction of HERG inhibition, solubility, and lipophilicityGeorge Papadatos, Muhammad Alkarouri, Valerie J Gillet, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
SLAS Discovery : Advancing Life Sciences R & D|August 21, 2019
Using Physicochemical Measurements to Influence Better Compound DesignShenaz B Bunally, Christopher N Luscombe, Robert J Young
Journal of Chemical Information and Modeling|March 12, 2009
Analysis of the calculated physicochemical properties of respiratory drugs: can we design for inhaled drugs yet?Timothy J Ritchie, Christopher N Luscombe, Simon J F Macdonald
Molecular Pharmaceutics|March 26, 2016
Integrating in Silico and in Vitro Approaches To Predict Drug Accessibility to the Central Nervous SystemYan-Yan Zhang, Houfu Liu, Scott G Summerfield, et al.
Drug Discovery Today|June 28, 2011
Getting physical in drug discovery II: the impact of chromatographic hydrophobicity measurements and aromaticityRobert J Young, Darren V S Green, Christopher N Luscombe, et al.
Journal of Computer-Aided Molecular Design|April 26, 2013
QSAR workbench: automating QSAR modeling to drive compound designRichard Cox, Darren V S Green, Christopher N Luscombe, et al.
European Journal of Medicinal Chemistry|July 20, 2002
On the mechanism of human intestinal absorptionMichael H Abraham, Yuan H Zhao, Joelle Le, et al.
Journal of Medicinal Chemistry|October 12, 2016
Correction to Evolution of a Novel, Orally Bioavailable Series of PI3Kδ Inhibitors from an Inhaled Lead for the Treatment of Respiratory DiseaseAugustin Amour, Nick Barton, Anthony W J Cooper, et al.
Journal of Medicinal Chemistry|July 19, 2016
Evolution of a Novel, Orally Bioavailable Series of PI3Kδ Inhibitors from an Inhaled Lead for the Treatment of Respiratory DiseaseAugustin Amour, Nick Barton, Anthony W J Cooper, et al.
Journal of Medicinal Chemistry|August 23, 2016
Correction to Evolution of a Novel, Orally Bioavailable Series of PI3Kδ Inhibitors from an Inhaled Lead for the Treatment of Respiratory DiseaseAugustin Amour, Nick Barton, Anthony W J Cooper, et al.
Journal of Chemical Information and Modeling|September 30, 2010
Lead optimization using matched molecular pairs: inclusion of contextual information for enhanced prediction of HERG inhibition, solubility, and lipophilicityGeorge Papadatos, Muhammad Alkarouri, Valerie J Gillet, et al.
Pageof 1